Data + Perspectives: HR-Positive Breast Cancer (1 of 5)

Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current...Подробнее

ER-Positive Metastatic Breast Cancer | Beyond the Guidelines: Clinical Investigator Perspectives ...Подробнее

Conceptualizing Guidelines to Manage Patients with HR–Positive, HER2-Negative Early Breast CancerПодробнее

Breast CANCER Every WOMAN Needs to KnowПодробнее

Early Stage Breast Cancer | 2022 OneOncology ConferenceПодробнее

Breast Cancer Screening and Prevention: A Clinician’s PerspectiveПодробнее

Data + Perspectives: Clinical Investigators Explore the Application of Recent Datasets in Current...Подробнее

Optimisation of Treatment Selection & Sequencing Decisions in ER+/HER2- Breast CancerПодробнее

Guideline Updates for Extended Endocrine Therapy Decision-Making in HR+, Early-Stage Breast CancerПодробнее

SOLAR-1 Trial in Metastatic Breast CancerПодробнее

HR+ Breast Cancer Management - OncBrothers (Rohit & Rahul Gosain) w/ Dr. Margaret Gatti-MaysПодробнее

Evaluating the Evidence and Parsing the Practicalities of Therapeutic Choices in HR+ Breast CancerПодробнее

JADPRO Live 2023 - Standardizing Extended Endocrine Therapy Decision-MakingПодробнее

Understanding Breast CancerПодробнее

What I Tell My Patients: Hormonal Therapy for Hormone Receptor-Positive Breast CancerПодробнее

Empowering Changes and Revolutionizing Treatment and Equity in Breast CancerПодробнее

Management of premenopausal HR+/HER2- breast cancer with micro-metastasisПодробнее

Neoadjuvant Therapy for HER2-positive Breast Cancer - Dr. Scott ChristensenПодробнее